Clinical Trials Directory

Trials / Unknown

UnknownNCT06267638

Comparison of Postoperative Pain Score Between Perioperative Intravenous Ketamine and Placebo in Patients Undergoing Unilateral Total Knee Arthroplasty Under General Anesthesia

Comparison of Postoperative Pain Score Between Perioperative Intravenous Ketamine and Placebo in Patients Undergoing Unilateral Total Knee Arthroplasty Under General Anesthesia, A Prospective Randomized Controlled Trial Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Ministry of Health, Thailand · Other Government
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to compare postoperative pain score between perioperative intravenous ketamine and placebo in patients undergoing unilateral total knee arthroplasty under general anesthesia. The main question\[s\] it aims to answer are: * Can perioperative intravenous ketamine reduce postoperative pain score during rest and movement at 0, 2, 4, 8, 12, 18, 24 hours better than no administration of Ketamine in patients undergoing Unilateral total knee arthroplasty under general anesthesia? * Can perioperative intravenous ketamine reduce morphine consumption in postoperative 24 hours, length of hospital stay, first time to receive opioid and side effect or complication from ketamine and opioid better than no administration of Ketamine in patients undergoing Unilateral total knee arthroplasty under general anesthesia? Participants will receive intravenous ketamine intraoperative TKA and comparison group will receive placebo that is normal saline. Researchers will compare perioperative intravenous ketamine and placebo to see postoperative pain score, morphine consumption in postoperative 24 hours, length of hospital stay, first time to receive opioid and side effect or complication from ketamine and opioid.

Conditions

Interventions

TypeNameDescription
DRUGKetamine groupParticipants will receive intraoperative ketamine during total knee arthroplasty
DRUGPlacebo groupParticipants will receive intraoperative normal saline during total knee arthroplasty

Timeline

Start date
2024-01-22
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-02-20
Last updated
2024-03-12

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06267638. Inclusion in this directory is not an endorsement.